Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Date

18 January 2024

Op-ed: There are far too many avoidable deaths in childbirth

For Financial Times, the Foundations CEO, Jayasree K. Iyer, writes about access to sexual and reproductive health in resource-poor countries, and discusses what pharmaceutical companies and the global health community can do to prevent avoidable deaths of women and infants.

Direct links

Read the full op-ed

Despite international commitments to eradicate avoidable deaths in childbirth, progress has stagnated, leaving vulnerable women and newborns without access to life-saving medicines, particularly in sub-Saharan Africa where maternal and neonatal mortality rates remain alarmingly high.

Iyer cites a concerning global situation where a woman dies every two minutes during pregnancy or childbirth, and over 6,000 neonatal deaths occur daily. While approximately 30 countries show progress in reducing maternal and newborn deaths, the majority of resource-poor nations experience stagnant or worsening mortality rates.

The op-ed questions the failure to meet the UN's sustainable development goals and highlights post-partum hemorrhage (PPH) as a leading cause of maternal deaths, emphasising the need to bridge the gap between established guidance and on-the-ground medical practices.

Iyer underscores the urgency of prioritising women's health globally, advocating for improved access to essential interventions like antibiotics and drugs for managing complications of labor. She calls on pharmaceutical companies to play a crucial role in providing affordable access to these products, emphasising the need for a coordinated effort from the global health community to address issues such as antimicrobial resistance and outdated attitudes hindering better maternal care.

Divya Verma

Head of Communications

dverma@accesstomedicinefoundation.org

Get in touch

In the media

Read other op-eds by Jayasree K. Iyer
Media

Op-ed: Climate change is unleashing a tsunami of infectious diseases–and we have fewer and fewer drugs that can treat them

11 December 2023
Media

Op-ed: Farmaceuten moeten niet zo gefixeerd zijn op winsten

23 October 2023
Media

Sickle cell cures are coming. African children can’t be left behind

12 July 2023

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved